Kun He Selected Research

B7-H1 Antigen

1/2022	PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma.
1/2019	FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1.
11/2017	FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond.
1/2016	FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kun He Research Topics

Disease

46	Neoplasms (Cancer) 01/2024 - 11/2005
28	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 08/2012
15	Disease Progression 05/2024 - 11/2007
15	Infections 01/2024 - 01/2014
15	Inflammation (Inflammations) 01/2021 - 01/2012
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2013
11	Nausea 01/2019 - 01/2012
10	Diarrhea 01/2024 - 01/2013
10	Neoplasm Metastasis (Metastasis) 07/2023 - 08/2012
10	Melanoma (Melanoma, Malignant) 01/2019 - 01/2012
9	Fatigue 01/2019 - 01/2012
8	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 11/2017
8	Non-alcoholic Fatty Liver Disease 01/2024 - 01/2017
6	Keratitis 01/2020 - 01/2012
6	Carcinoma (Carcinomatosis) 01/2019 - 01/2016
6	Vomiting 06/2017 - 01/2013
6	Leukemia 11/2013 - 08/2003
5	Cognitive Dysfunction 04/2024 - 12/2021
5	Type 2 Diabetes Mellitus (MODY) 02/2024 - 10/2018
5	Pancreatitis 05/2023 - 01/2017
4	Liver Neoplasms (Liver Cancer) 01/2024 - 01/2015
4	Liver Cirrhosis (Hepatic Cirrhosis) 10/2023 - 01/2013
4	Constipation 01/2019 - 10/2014
4	Sepsis (Septicemia) 12/2018 - 10/2013
4	Exanthema (Rash) 07/2017 - 01/2013
4	Breast Neoplasms (Breast Cancer) 01/2016 - 04/2007
3	Hypertension (High Blood Pressure) 12/2023 - 12/2015
3	Adenocarcinoma 03/2023 - 08/2015
3	Glioblastoma (Glioblastoma Multiforme) 11/2022 - 12/2019
3	Circulating Neoplastic Cells 01/2022 - 11/2020
3	Hemorrhage 12/2021 - 03/2018
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 08/2017
3	Arthralgia (Joint Pain) 01/2019 - 10/2014
3	Body Weight (Weight, Body) 10/2018 - 01/2017
3	Necrosis 08/2018 - 07/2014
3	Asthenia 06/2017 - 01/2013
3	Neutropenia 06/2017 - 01/2013
3	Colorectal Neoplasms (Colorectal Cancer) 06/2017 - 10/2016
3	Anemia 06/2017 - 01/2013
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2010 - 10/2004
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2024 - 01/2020
2	Glioma (Gliomas) 01/2021 - 01/2020
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2017
2	Insulin Resistance 09/2020 - 11/2017

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 05/2024 - 10/2004
13	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2013
12	Peptides (Polypeptides)IBA 05/2024 - 01/2012
8	Alanine Transaminase (SGPT)IBA 07/2023 - 01/2012
7	pembrolizumabIBA 01/2022 - 01/2016
7	PlatinumIBA 01/2019 - 01/2016
5	Amyloid (Amyloid Fibrils)IBA 04/2024 - 01/2023
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2024 - 01/2014
5	CholesterolIBA 12/2023 - 07/2014
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 08/2015
5	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2018 - 01/2012
5	ErbB Receptors (EGF Receptor)IBA 06/2018 - 07/2014
5	Messenger RNA (mRNA)IBA 01/2018 - 01/2012
4	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 04/2014
4	B7-H1 AntigenIBA 01/2022 - 01/2016
4	CytokinesIBA 12/2018 - 02/2014
4	InflammasomesIBA 10/2018 - 11/2016
4	Anaplastic Lymphoma KinaseIBA 11/2017 - 10/2014
4	LigandsIBA 11/2017 - 10/2015
3	oxidized low density lipoproteinIBA 01/2024 - 10/2018
3	Triglycerides (Triacylglycerol)IBA 01/2024 - 08/2018
3	Liposomes (Liposome)IBA 12/2023 - 11/2007
3	Sorafenib (BAY 43-9006)FDA Link 09/2023 - 07/2022
3	AcidsIBA 05/2023 - 11/2016
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2016
3	LipopolysaccharidesIBA 12/2018 - 10/2015
3	IronIBA 01/2018 - 01/2016
3	Therapeutic UsesIBA 01/2018 - 01/2012
3	IpilimumabIBA 10/2017 - 07/2017
3	NivolumabIBA 07/2017 - 01/2016
3	CrizotinibIBA 11/2016 - 10/2014
2	Metabotropic Glutamate 5 ReceptorIBA 04/2024 - 01/2024
2	Bile Acids and Salts (Bile Acids)IBA 04/2024 - 01/2024
2	Liraglutide FDA Link 02/2024 - 10/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 12/2022
2	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2023
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2023 - 01/2019
2	Neostigmine (Neostigmine Bromide)IBA 01/2023 - 01/2023
2	janagliflozinIBA 01/2023 - 12/2022
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2022 - 10/2021
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2022 - 07/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 11/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2020 - 02/2020

Therapy/Procedure

32	Therapeutics 04/2024 - 11/2007
13	Drug Therapy (Chemotherapy) 05/2024 - 01/2013
8	Lasers (Laser) 05/2024 - 10/2004
6	Radiotherapy 09/2023 - 05/2017
5	Hepatectomy 01/2024 - 01/2016
4	Immunotherapy 01/2023 - 01/2018
2	Liver Transplantation 04/2023 - 01/2017
2	Enteral Nutrition (Feeding, Tube) 01/2023 - 06/2013
2	Intravenous Infusions 01/2022 - 10/2017
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 01/2019
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 09/2017